FDA warns about safety risks of tailored weight-loss drugs

The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic.

Related Keywords

Bengaluru ,Karnataka ,India ,Denmark ,Danish , ,Novo Nordisk Novob Co Ozempic ,Drug Administration ,Thomson Reuters Trust Principles ,Novo Nordisk Novob Co Wegovy ,Reuters ,Novo Nordisk ,Mariam Sunny ,Thomson Reuters Trust ,